Is This the Moment to Truly Transform the ROI of Higher Education?
Scaling What Works
Is This the Moment to Truly Transform the ROI of Higher Education?
Part 2: In No Surprises Act, Arbitration Design Is Key to Realizing Expected Savings
Commercial Sector Prices
Part 2: In No Surprises Act, Arbitration Design Is Key to Realizing Expected Savings
Part 1: Fulfilling the Promises of the Surprise Billing Ban
Commercial Sector Prices
Part 1: Fulfilling the Promises of the Surprise Billing Ban
‘It’s Just Simply the Cost Per Dose That Americans Are Being Charged More For’
Drug Prices
‘It’s Just Simply the Cost Per Dose That Americans Are Being Charged More For’
Inside UNC’s Innovative Approach to Improving Student Graduation Rates
Scaling What Works
Inside UNC’s Innovative Approach to Improving Student Graduation Rates
Congress Grills Major Drug Manufacturer on Anticompetitive Tactics and Price Gouging
Drug Prices
Congress Grills Major Drug Manufacturer on Anticompetitive Tactics and Price Gouging
A Unique Workforce Development Program Shows Promise in Reducing Inequality and Boosting Economic Growth
Evidence & Evaluation
A Unique Workforce Development Program Shows Promise in Reducing Inequality and Boosting Economic Growth
Podcast: Higher Education’s Accountability Crisis
Higher Education
Podcast: Higher Education’s Accountability Crisis
Deep Dive with Laura Arnold
Policies Take Aim at Rising Health Care Costs Hurting Families, Employers and Taxpayers
Commercial Sector Prices
Policies Take Aim at Rising Health Care Costs Hurting Families, Employers and Taxpayers
President Biden Called on Congress to Lower Drug Prices. What’s Next?
Drug Prices
President Biden Called on Congress to Lower Drug Prices. What’s Next?
New Laws Take Aim at Drug Prices, But Stronger Action Needed
Drug Prices
New Laws Take Aim at Drug Prices, But Stronger Action Needed
Podcast: Has Gun Reform Reached a Tipping Point?
Criminal Justice
Podcast: Has Gun Reform Reached a Tipping Point?
Deep Dive with Laura Arnold
After Sluggish Start, Is the Biosimilar Market Poised for Growth?
Drug Prices
After Sluggish Start, Is the Biosimilar Market Poised for Growth?
Evidence & Evaluation
A Replication Randomized Controlled Trial of Stay the Course, Measuring Enrollment and Degree Completion by Low-Income Community College Students
Drug Pricing Reform Enters a Big, New Battleground: States
Drug Prices
Drug Pricing Reform Enters a Big, New Battleground: States
Proving That Skills Training Programs Can Help Working Families
Evidence & Evaluation
Proving That Skills Training Programs Can Help Working Families
Podcast: Democracy in Crisis
Podcast: Democracy in Crisis
Deep Dive with Laura Arnold
Evidence & Evaluation
Webinar Offers Practical Advice on Applying for Grant Funding with Arnold Ventures’ Evidence-Based Policy Initiative
How One Colorado Organization Brought Down Health Care Prices
Commercial Sector Prices
How One Colorado Organization Brought Down Health Care Prices
Landmark SCOTUS Ruling Opens the Door for Stronger State Regulation of PBMs
Drug Prices
Landmark SCOTUS Ruling Opens the Door for Stronger State Regulation of PBMs
A Drug is 90 Percent Effective at Preventing HIV. It Costs Up to $1,800 Per Month.
Drug Prices
A Drug is 90 Percent Effective at Preventing HIV. It Costs Up to $1,800 Per Month.
The Right Way to Cancel Student Debt
Higher Education
The Right Way to Cancel Student Debt
Evidence & Evaluation
Earnings and Employment Impacts in the English for Advancement (EfA) Randomized Trial — a Workforce Development Program for English Language Learners
CMS’ Proposed Rule on 'Breakthrough' Medical Devices Builds on a Flawed System
Provider Payment Incentives
CMS’ Proposed Rule on ‘Breakthrough’ Medical Devices Builds on a Flawed System
About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
- Criminal Justice
- Health
- Public Finance
- Higher Education & Career Pathways
- Infrastructure
- Evidence & Evaluation
